Four PHRI researchers will be presenting at the 18th World Stroke Congress (WSC 2026), taking place October 21-23, 2026, in Seoul, Korea.
Their presentations include findings from PHRI-led studies ENRICH-AF, OCEANIC-STROKE, and PURE, as well as sessions on stroke prevention, new therapies, and intracerebral haemorrhage.
Here’s a look at who’s presenting and what they’ll be covering:
Raed Joundi, PHRI scientist:
- Presenter: Effect of factor XIa inhibitor asundexian on ischemic stroke recurrence according to baseline infarct pattern: MRI substudy of OCEANIC-STROKE trial.
- Presenter: Stroke incidence, case fatality, and disability in 25 high-, middle-, and low-income countries: the PURE study
Aristeidis Katsanos, PHRI scientist:
- Presenter: Finetuning decisions on stroke patients with right-left shunts with TCD
- Presenter: The next frontiers in intracerebral haemorrhage
Mike Sharma, PHRI senior scientist:
- Moderator and Presenter: Personalizing Prevention: Integrating Clinical Evidence Into Person-Centered Stroke Care – Industry Symposium Sponsored by Medscape Education Global, supported by an independent educational grant from Bayer
- Presenter: Evidence for the Individual: Analyzing Phase 3 Data
- Presenter: Factor XI inhibitors for secondary stroke prevention: recurrence & severity
Ashkan Shoamanesh, PHRI senior scientist
- Moderator: PARALLEL INDUSTRY SYMPOSIUM 04
What’s New, What’s Next: Clinical Trial Updates in Secondary Stroke Prevention – Industry Symposium Sponsored by Medscape Education Global, supported by an independent educational grant from Bayer - Presenter: Edoxaban for Stroke Prevention In Intracranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF): An Open-label, blinded endpoint, parallel group randomized trial
- Presenter: Factor XII inhibitors in different stroke mechanisms: lessons from oceanic
- Presenter: FXI Inhibition in Motion: Rapid Fire Updates
- Presenter: Conversation With the Experts: Integrating New Data Into Future Practice
